Pharmacist Led Educational Intervention on QOL, Medication Adherence & Satisfaction on Patients With Type 1 DM
Recruiting now · Not applicable
Conditions studied: Diabetes Mellitus, Type 1
In brief
There was no previous study in Iraq to evaluate the efficacy of pharmacist-led educational intervention on patient glycemic control, quality of life and medication adherence among type 1 diabetic patients in Iraq. Improving diabetes patients' information's about their disease control, the role of insulin and the right technique to administer it, how to deal with hyper- and hypoglycemia, about their diet and exercise. It is important to conduct a study to evaluate the pharmacist's role in education and improving patients' quality of life.
Key facts
- Study ID
- NCT06547970
- Run by
- University of Baghdad
- People needed
- 60
- Starts
- 2024-02-01
- Expected to finish
- 2024-09-01
- Last updated by the study team
- 2024-08-12
Who can join
Age: 16 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- - Patients age ≥ 16 years old who can speak and read the Arabic language.
- Had been diagnosed with T1DM for at least 6 months ago.
- Had uncontrolled hyperglycemia (glycosylated hemoglobin HbA1C ≥7% and/or fasting blood glucose >130 mg/dl)
- Patients on the same regimen the last 3 months.
- patients (or parents) acceptance to participate in the study.
You may not qualify if…
- 1-Patient who have hearing, speech or cognitive deficits that would impair understanding of the questions and receiving the education.
- 2- Patients with comorbid conditions that may interfere with the study such as asthma, thyroid disorders, adrenal gland disorders, celiac disease, or significant renal impairment.
- 3-Patients who are taking corticosteroids. 4- Patients who required changing their insulin regimen, increasing the dose >20% of the previous dose. (21) 5- Patients with conditions that affect red blood cell turnover (hemolytic and other anemias, G-6-PD deficiency, recent blood transfusion, use of drugs that stimulate erythropoiesis, end stage kidney disease and pregnancy.
- 6-Patients unwilling to participate.
Where it is running
- Al-kindy Specialized center for endocrine diseases and diabetes — Baghdad, Iraq (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.